WELD CAPITAL MANAGEMENT LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELD CAPITAL MANAGEMENT LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$841,000
+26.7%
31,996
+29.2%
0.33%
+27.7%
Q2 2020$664,000
+32.3%
24,769
-23.4%
0.26%
+182.6%
Q3 2019$502,000
+46.4%
32,345
+62.0%
0.09%
+46.0%
Q2 2019$343,000
-49.7%
19,965
-57.1%
0.06%
-58.8%
Q4 2018$682,00046,5920.15%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders